Call Options Transactions Made in Q3 2024 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q3 2024. The information is specifically focused on institutions that hold call options of Celldex Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
350KNew |
$11.2M - $15.6M
|
350K
$7M
|
|
Nov 14, 2024
Q3 2024
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
306KNew |
$9.79M - $13.6M
|
306K
$6.11M
|
|
Nov 14, 2024
Q3 2024
|
Integral Health Asset Management, LLC
|
BUY
|
CALL |
300KNew |
$9.62M - $13.4M
|
300K
$6M
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
136KNew |
$4.35M - $6.05M
|
136K
$2.72M
|
|
Nov 14, 2024
Q3 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
BUY
|
CALL |
100KNew |
$3.21M - $4.46M
|
100K
$2M
|
|
Nov 14, 2024
Q3 2024
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
90.2KNew |
$2.89M - $4.02M
|
90.2K
$1.8M
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
71.7K+ 587.7% |
$2.3M - $3.19M
|
83.9K
$1.68M
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
66.3K+ 158.99% |
$2.13M - $2.95M
|
108K
$2.16M
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
BUY
|
CALL |
30.6KNew |
$981K - $1.36M
|
30.6K
$612K
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
CALL |
30KNew |
$962K - $1.34M
|
30K
$600K
|
|
Nov 14, 2024
Q3 2024
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
13.1KNew |
$420K - $584K
|
13.1K
$262K
|
|
Oct 30, 2024
Q3 2024
|
Belvedere Trading LLC
|
BUY
|
CALL |
6KNew |
$192K - $267K
|
6K
$120K
|
|
Nov 13, 2024
Q3 2024
|
Torno Capital, LLC
Cohasset, MA |
BUY
|
CALL |
5.3KNew |
$170K - $236K
|
5.3K
$106K
|